Cipla Ltd.

₹1,314.7

-9.6 (-0.7%)

CIPLA Share Price

Pharmaceuticals & Biotechnology

As on March 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,06,259 Cr

P/E Ratio20.14

Dividend Yield0.61 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,325.4	Bearish
10-DMA	1,328.76	Bearish
20-DMA	1,334.83	Bearish
50-DMA	1,366.58	Bearish
100-DMA	1,446.04	Bearish
200-DMA	1,484.89	Bearish

Historical Performance

1 Year

-10.1%

3 Years

50.3%

5 Years

63.1%

10 Years

145.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	2,75,476	2,57,741	2,27,531	2,17,633	1,91,596
Total Expenditure	2,04,197	1,94,830	1,77,628	1,72,514	1,49,109
Other Income	8,619	7,466	5,121	3,217	2,698
Operating Profit	79,898	70,376	55,024	48,337	45,184
Interest	620	899	1,095	1,063	1,607
Depreciation	11,069	10,510	11,721	10,519	10,677
Profit Before Tax	68,208	57,019	40,384	34,933	32,901
Consolidated Net Profit	52,725	41,215	28,019	25,168	24,049
Adjusted EPS	65	51	35	31	30

Compounded Sales Growth

10 Years:19.4

5 Years:10

3 Years:4.8

TTM:1.3

Compounded Profit Growth

10 Years:34.9

5 Years:27.8

3 Years:15.9

TTM:5

Stock Price CAGR

10 Years:9.4

5 Years:10.3

3 Years:14.7

TTM:-10.1

Return on Equity

10 Years:16.9

5 Years:29.8

3 Years:34.7

last year:65.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	1,615	1,615	1,614	1,614	1,613
Total Reserves	3,09,178	2,64,584	2,31,845	2,06,363	1,81,232
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	-310	819	1,835	6,217	16,601
Other Current Liabilities	7,730	8,910	10,076	7,698	10,932
Short Term Borrowings	801	2,470	1,879	3,933	3,347
Total Liabilities	3,67,422	3,21,300	2,90,067	2,66,523	2,48,372
Capital Work in Progress	12,128	8,643	6,892	3,829	5,708
Long Term Loans & Advances	10,384	8,444	8,495	7,364	6,456
Currents Investments	72,932	48,070	30,899	21,950	22,864
Short Term Loans and Advances	34,814	31,342	25,632	15,071	10,310
Total Current Assets	2,32,490	1,93,924	1,68,051	1,47,108	1,31,810
Total Assets	3,67,422	3,21,300	2,90,067	2,66,523	2,48,372
Adjusted Book Value	385	330	289	258	227

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 20.14, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a moderate 3-year price CAGR of 14.7%, reflecting average market performance.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹79898 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹275476 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 880812

No. of Shares: 670 (Approx)

Performance:-11.9%

P/L: ₹-119188

NIFTY Performance: 3.4%

1 day Top Gainers